For most adults, caffeine is something that kickstarts their day. Research has found that caffeine therapy may benefit premature babies.
Any baby born before 37 weeks of gestation is classified as premature. Babies that are born very prematurely, i.e., at less than 32 weeks of gestational age or have a very low birth weight (less than 1500 grams), have been found to have a number of medical problems such as jaundice. Some problems may last until childhood and adulthood. One of the major problems with premature birth is the baby’s lungs are not fully developed and functional. Preterm infants have been noted to have poor expiratory air flow compared to babies who were born at full term and had a normal birth weight.
What does research show about caffeine therapy for premature babies?
In 2017, the American Thoracic Society reported the effects of caffeine on neonatal lung health. The Caffeine for Apnea of Prematurity (CAP) study enrolled more than 2000 infants at 35 hospitals. The study found that caffeine treatment in newborn preterm infants reduced apnea (suspended breathing), shortened the period for which the baby required assisted ventilation, and improved expiratory flow rates up to the age of 11 years. The beneficial effects of caffeine have been observed in the short-term, but the long-term effects on the respiratory health of the premature babies are unknown. Interestingly, the study did not reveal any harmful effects from the therapy.
Parents may feel concerned, even overwhelmed, when healthcare providers suggest caffeine therapy for a tiny infant. Studies have looked at the benefits and risks of caffeine therapy for preterm babies. It will be reassuring to parents to learn that:
Some of the therapeutic effects of caffeine include:
Some of the noted disadvantages of caffeine therapy in preterm infants include: